Elon Musk unveils “Macrohard,” a Tesla and xAI AI system designed to perform complex computer tasks and potentially replicate ...

A new AI startup is betting that it has found a powerful data source to teach robots to do more valuable work: online videos. Rhoda AI has raised $450 million in funding to develop and deploy a new ...

NEW YORK--(BUSINESS WIRE)--KKR & Co. Inc., a leading global investment firm, today announced that it has entered into a definitive agreement to acquire Arctos Partners (“Arctos”), a premier ...

Artificial Intelligence is rapidly transforming our world, but its growing complexity demands massive computational power and energy. Optical Neural Networks (ONNs), which use light instead of ...

Elon Musk’s SpaceX said Monday it is acquiring artificial-intelligence startup xAI, a move that significantly expands the rocket and satellite company’s ambitions in data centers and advanced ...

Disney has the right to buy back the NFL's stake beginning in July 2034, with the league holding an option to acquire more of ESPN. By Alex Weprin Senior Editor ESPN is valued at about $30 billion, ...

A combined Tesla-SpaceX entity would reach $2.6T in value but faces antitrust scrutiny and significant dilution risks for Tesla shareholders. Betting markets assign 15% odds to a Tesla-SpaceX merger ...

From the Department of Bizarre Anomalies: Microsoft has suppressed an unexplained anomaly on its network that was routing traffic destined to example.com—a domain reserved for testing purposes—to a ...

Jan 23 (Reuters) - EquipmentShare.com shares rose 16.3% in their Nasdaq debut on Friday, valuing the construction rental firm at $7.16 billion and signaling strong investor appetite for its ...

Laura Coates speaks with retired Navy Admiral Nancy Lacore, who was removed from her post by Defense Secretary Pete Hegseth and is now running for Congress in South Carolina. Lacore says women in the ...

GSK Plc agreed to buy Rapt Therapeutics, a US-based biotech developing treatments for patients with inflammatory and immunologic diseases, in a deal valued at $2.2 billion. The UK drug company will ...